Company insight
Sustainability meets suitability with a focus on total system efficiencies
Improving supply chain sustainability is a focus for the pharma industry, but it brings unique difficulties, especially for temperature-controlled elements. Working with a consultative partner like CSafe leads to solutions that deliver both sustainability and suitability.
ustainability has become a standard point of focus for the pharma industry and is often uttered in the same breath as the all-important concept of efficiency. Both go hand-in-hand, though extending those concepts into all aspects of the supply chain brings many challenges. As sustainability continues its climb up the list of priorities, companies are asking their supply chain partners to help them build it into every aspect of their operations.
S
As a supplier of end-to-end temperature-controlled shipping solutions, CSafe understands the challenges pharma companies face in marrying efficiency with sustainability and takes a holistic approach. CSafe’s emphasis on reusable models across its solution portfolio helps deliver critical life-enhancing products while supporting a more sustainable future.
temperature-controlled packaging solution to its partner.
Sustainability meets suitability A key objective for pharma companies and their supply chain partners is to find solutions that are not only sustainable but fully meet the required standards for shipping high-value and sensitive items. This requires a holistic approach that balances sustainability and suitability, and factors in all aspects of product design and performance from the initial concept through to delivery and launch. With CSafe’s full line of reusable solutions, the prioritisation of a sustainable solution starts with the initial concept design brief. An example of this is with the newly launched Silverskin RE, a reusable thermal cover, developed from the start with a focus on energy-efficient materials, sustainable manufacturing
“Embedded into CSafe’s product design strategy is a recognition that a holistic approach to sustainability is essential.”
CSafe focuses on what can be controlled from a process and product perspective when it comes to tracking Scope 1, 2 and 3 emissions, in addition to tracking of product GHG emissions. CSafe supports pharma companies in tracking of this type of data but sets expectations on what is outside of the parameters for control, essentially the transportation on the shipment lane. Understanding pharma companies’ sustainability goals is the very first step CSafe takes in providing the essential
36
procedures and, ultimately, a reliable refurbishment service. CSafe has replicated the reusable service model that it is known for across its portfolio of bulk air cargo solutions. Embedded into CSafe’s product design strategy is a recognition that a holistic approach to sustainability is essential.
Balancing sustainability with reliability includes the selection of best-in-class energy-efficient materials and utilisation of technology like thermal simulation software. This technology can assess
a product’s thermal behaviour with minimal time in an environmental chamber, optimise packaging selection and better inform logistics choices, allowing for proactive quality management rather than reactive testing. CSafe engages early with its customers to understand their temperature-control and sustainability needs to provide an optimal reusable solution that performs every time.
Choose right, minimise failures Another key aspect to the selection of a sustainable solution is understanding the performance in the real world. Tracking of real-time GPS location and conditional data in transit provides pharma companies visibility of their actual shipment lanes. Choosing a reliable, high-performing solution initially minimises the chances of temperature excursions due to equipment failure. Real-time monitoring enhances this reliability by providing a constant overview, triggering alerts for any breaches, and offering accountability through a transparent audit trail. Providing real-time analytics to accelerate decision-making is key to driving down costs, time and ultimately energy spent when it comes to the selection and deployment of a temperature-controlled solution. Better yet, understanding total system efficiencies and working with a consultative partner will ultimately lead to a sustainable solution. ●
https://csafeglobal.com
www.worldpharmaceuticals.net
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85
